• Explore /
  • Poster
  • / Safety and efficacy of enfortumab vedotin in patients with metastatic/locally advanced urothelial cancer: Real-world evidence from a European database.

Safety and efficacy of enfortumab vedotin in patients with metastatic/locally advanced urothelial cancer: Real-world evidence from a European database.

Abstract Poster

Authors

null

Stefanie Zschaebitz

National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany

Stefanie Zschaebitz , Niklas Klümper , Thomas Büttner , Nina Holzwarth , Nadine Biernath , Alexander Höllein , Guenter Niegisch , Daniel Seidl , Can Aydogdu , Analena Handke , Pia Paffenholz , Katrin Schlack , Richard Cathomas , Eva Erne , Severine Banek , Robert Tauber , Jozefina Casuscelli , Anna Katharina Seitz , Viktor Grünwald , Christopher Darr

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Quality of Care/Quality Improvement and Real-World Evidence

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 553)

DOI

10.1200/JCO.2024.42.4_suppl.553

Abstract #

553

Poster Bd #

E2

Abstract Disclosures

Similar Posters

First Author: Erika Richtig

First Author: Evangelia Vlachou

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Safety and efficacy of nanosomal docetaxel lipid suspension (NDLS) in patients with advanced gastric adenocarcinoma.

Safety and efficacy of nanosomal docetaxel lipid suspension (NDLS) in patients with advanced gastric adenocarcinoma.

First Author: Vikas S. Ostwal

First Author: Ilya Tsimafeyeu